Cancer screening rates rebound
1d
MedPage Today on MSNKeytruda Not Cost-Effective in Locally Advanced Cervical Cancer, Study SaysDespite a proven survival benefit, the addition of pembrolizumab (Keytruda) to chemoradiotherapy for newly diagnosed locally ...
Bandi and her team found that past-year cervical cancer screenings in 2023 remained at 14%, which is below pre-pandemic ...
Four of the country’s leading health organisations have come together as part of an Australian Government-funded campaign to ...
Cervical cancer incidence is rising, with rural and minoritized populations experiencing worse outcomes due to suboptimal ...
A recent CDC report further demonstrates the effectiveness of the HPV vaccine against cervical cancer. HPV is a sexually ...
After a long decline, cervical cancer rates are rising in rural counties, increasing a gap with urban counties, a new study ...
Most of the women under 30 with cervical cancer in the Netherlands have not been vaccinated against HPV. A study conducted by ...
Researchers from the University of Chicago Medicine Comprehensive Cancer Center have demonstrated the potential of a novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results